Terumo was founded in 1921 and our aspiration is embodied in our corporate mission, Contributing to Society through Healthcare.¡± which has been held up as our highest value over the company¡¯s 90 year¡¯s history.
Booth No. D014
Lunchtime Activities | |
Ultimaster : What We Expect from the Latest Generation Stent? | |
Organized by CVRF and Supported by Educational Grant from Terumo Korea Corporation | |
Tuesday, April 25 12:45 PM - 1:45 PM Presentation Theater, Level 1 |
|
Moderator(s): Myung-Ho Jeong, Sunarya Soerianata | |
Panelist(s): Aloke V. Finn, Byung-Hee Hwang, Sung Uk Kwon, Kyounghoon Lee, Seung Uk Lee, Young-Hyo Lim | |
12:45 PM | Opening Remark
Speaker : Myung-Ho Jeong
|
12:50 PM | Comparison Between Ultimaster and Xience from Pathological View
Lecturer : Aloke V. Finn
|
1:10 PM | Treatment of Bifurcation Lesions with a Thin-strut Drug Eluting Stent with Bioresorbable Polymer: Three-year Clinical Outcomes of the CENTURY II Trial
Lecturer : Sung Uk Kwon
|
1:30 PM | Q & A (Discussion) |
1:40 PM | Closing Remark
Speaker : Sunarya Soerianata
|